Friday, October 23, 2026

EUR/CHF Is 3% Down In The Last 21 Sessions

EUR/CHF Is 3% Down In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 3.64% for the last 21 sessions. At 12:06 EST on Friday, 21 June, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 5.847% up from its 52-week low and 3.746% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.11%, a negative 0.15%, and a positive 0.27%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.37% (last week), 0.30% (last month), and 0.27% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy flat lines below 158.00, bulls turn cautious amid subdued USD price action. According to FXStreet on Wednesday, 19 June, "Apart from this, speculations that Japanese authorities might intervene to prop up the domestic currency further contribute to capping the USD/JPY pair. ", "This, however, does little to impress the JPY bulls or provide any meaningful impetus to the USD/JPY pair, though subdued US Dollar (USD) price action continues to act as a headwind for spot prices."
  • Usd/jpy price analysis: steadies as asian session begins, above 158.00. According to FXStreet on Wednesday, 19 June, "The USD/JPY remains flat as Thursday's Asian session begins, yet it printed minuscule gains of 0.15% on Wednesday. ", "Those reasons justify further USD/JPY upside, but fears that Japanese authorities might intervene in the markets keep traders cautious, with the major advancing steadily."
  • Usd/jpy holds steady near 158.00 mark, just below its highest level since late April. According to FXStreet on Thursday, 20 June, "This, along with the US bond yields and Fedspeak, will influence the USD price dynamics and provide some impetus to the USD/JPY pair. ", "Apart from this, the underlying bullish tone across the global equity markets is seen denting demand for the safe-haven JPY and lending support to the USD/JPY pair. "
  • Usd/jpy bulls turn cautious near 159.00, highest since April amid intervention fears. According to FXStreet on Friday, 21 June, "This results in the further widening of the US-Japan rate differential, which is seen as another factor weighing on the JPY and lending support to the USD/JPY pair. ", "Nevertheless, the USD/JPY pair remains on track to end in positive territory for the second straight week as investors now look forward to the release of the global flash PMI prints for some meaningful impetus. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,475 source documents archived
Query this data → isubstrate.com